What fires prometheus?. The link between inflammation and regeneration following chronic liver injury

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 5, 2008, Pages 855-873

  Viebahn, Cornelia S ^a   Yeoh, George C T ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cytokine; Inflammation; Liver progenitor cell; Liver regeneration; T cell

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CELL HETEROGENEITY; CELL INTERACTION; CELL SPECIFICITY; DISEASE ASSOCIATION; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; ISOLATION PROCEDURE; LIVER CANCER; LIVER CELL; LIVER DISEASE; LIVER INJURY; LIVER PARENCHYMA; LIVER REGENERATION; METABOLISM; NOMENCLATURE; NONHUMAN; REVIEW; STEM CELL;

ANIMALS; CHRONIC DISEASE; CYTOKINES; HEPATITIS; HEPATOCYTES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER DISEASES; LIVER REGENERATION; STEM CELLS;

EID: 40149091686     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.11.025     Document Type: Review

References (111)

1. Agrati C., Martini F., Nisii C., Oliva A., D'Offizi G., Narciso P., et al. CD1d expression by hepatocytes is a main restriction element for intrahepatic T-cell recognition. Journal of Biological Regulators and Homeostatic Agents 19 (2005) 41-48
2. Akhurst B., Matthews V., Husk K., Smyth M.J., Abraham L.J., and Yeoh G.C. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 41 (2005) 327-335
3. Alison M.R. Characterization of the differentiation capacity of rat-derived hepatic stem cells. Seminars in Liver Disease 23 (2003) 325-336
4. Alison M.R., and Lovell M.J. Liver cancer: The role of stem cells. Cell Proliferation 38 (2005) 407-421
5. Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer 4 (2004) 540-550
6. Bataller R., and Brenner D.A. Liver fibrosis. Journal of Clinical Investigation 115 (2005) 209-218
7. Bertolino P., Trescol-Biemont M.C., and Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. European Journal of Immunology 28 (1998) 221-236
8. Bertolino P., Trescol-Biemont M.C., Thomas J., Fazekas de St Groth B., Pihlgren M., Marvel J., et al. Death by neglect as a deletional mechanism of peripheral tolerance. International Immunology 11 (1999) 1225-1238
9. Bisgaard H.C., Muller S., Nagy P., Rasmussen L.J., and Thorgeirsson S.S. Modulation of the gene network connected to interferon-gamma in liver regeneration from oval cells. American Journal of Pathology 155 (1999) 1075-1085
10. Bowen D.G., McCaughan G.W., and Bertolino P. Intrahepatic immunity: A tale of two sites?. Trends in Immunology 26 (2005) 512-517
11. Bowen D.G., Zen M., Holz L., Davis T., McCaughan G.W., and Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. Journal of Clinical Investigation 114 (2004) 701-712
12. Braun K.M., Thompson A.W., and Sandgren E.P. Hepatic microenvironment affects oval cell localization in albumin-urokinase-type plasminogen activator transgenic mice. American Journal of Pathology 162 (2003) 195-202
13. Braun L., Mikumo R., and Fausto N. Production of hepatocellular carcinoma by oval cells: Cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Research 49 (1989) 1554-1561
14. Brooling J.T., Campbell J.S., Mitchell C., Yeoh G.C., and Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 41 (2005) 906-915
15. Chen M., Tabaczewski P., Truscott S.M., Van Kaer L., and Stroynowski I. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. Journal of Immunology 175 (2005) 1047-1055
16. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379-1383
17. Crispe I.N., Dao T., Klugewitz K., Mehal W.Z., and Metz D.P. The liver as a site of T-cell apoptosis: Graveyard, or killing field?. Immunological Reviews 174 (2000) 47-62
18. Cua D.J., and Kastelein R.A. TGF-beta, a 'double agent' in the immune pathology war. Nature Immunology 7 (2006) 557-559
19. Culafic D.M., Mirkovic D.S., Vukcevic M.D., and Rudic J.S. Plasma and platelet serotonin levels in patients with liver cirrhosis. World Journal of Gastroenterology 13 (2007) 5750-5753
20. Davies R.A., Knight B., Tian Y.W., Yeoh G.C., and Olynyk J.K. Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor. Carcinogenesis 27 (2006) 1607-1616
21. Dezso K., Jelnes P., Laszlo V., Baghy K., Bodor C., Paku S., et al. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. American Journal of Pathology 171 (2007) 1529-1537
22. Doherty D.G., and O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunological Reviews 174 (2000) 5-20
23. Evarts R.P., Hu Z., Fujio K., Marsden E.R., and Thorgeirsson S.S. Activation of hepatic stem cell compartment in the rat: Role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth and Differentiation 4 (1993) 555-561
24. Falkowski O., An H.J., Ianus I.A., Chiriboga L., Yee H., West A.B., et al. Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. Journal of Hepatology 39 (2003) 357-364
25. Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Research 16 (1956) 142-148
26. Fausto N. Liver regeneration. Journal of Hepatology 32 (2000) 19-31
27. Fausto N. Tweaking liver progenitor cells. Nature Medicine 11 (2005) 1053-1054
28. Fausto N., Campbell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) S45-S53
29. Fausto N., and Riehle K.J. Mechanisms of liver regeneration and their clinical implications. Journal of Hepato-Biliary-Pancreatic Surgery 12 (2005) 181-189
30. Forsberg L., Floren C.H., Hederstrom E., and Prytz H. Ultrasound examination in diffuse liver disease. Clinical significance of enlarged lymph nodes in the hepato-duodenal ligament. Acta Radiologica 28 (1987) 281-284
31. Fougere-Deschatrette C., Imaizumi-Scherrer T., Strick-Marchand H., Morosan S., Charneau P., Kremsdorf D., et al. Plasticity of hepatic cell differentiation: Bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 24 (2006) 2098-2109
32. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry 275 (2000) 2247-2250
33. Galbiati F., Rogge L., and Adorini L. IL-12 receptor regulation in IL-12-deficient BALB/c and C57BL/6 mice. European Journal of Immunology 30 (2000) 29-37
34. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994) 965-968
35. Hacker H.J., Steinberg P., Toshkov I., Oesch F., and Bannasch P. Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/dl-ethionine-supplemented diet. Carcinogenesis 13 (1992) 271-276
36. Haque S., Haruna Y., Saito K., Nalesnik M.A., Atillasoy E., Thung S.N., et al. Identification of bipotential progenitor cells in human liver regeneration. Laboratory Investigation 75 (1996) 699-705
37. Hasuike S., Ido A., Uto H., Moriuchi A., Tahara Y., Numata M., et al. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. Journal of Gastroenterology and Hepatology 20 (2005) 1753-1761
38. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., and Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169 (1989) 59-72
39. Hines I.N., Kremer M., Isayama F., Perry A.W., Milton R.J., Black A.L., et al. Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology 46 (2007) 229-241
40. Ishii H., and Saito H. Perihepatic lymphadenopathy in chronic liver diseases. Journal of Gastroenterology and Hepatology 15 (2000) 695-696
41. Jaeschke H., and Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver International 26 (2006) 912-919
42. Jakubowski A., Ambrose C., Parr M., Lincecum J.M., Wang M.Z., Zheng T.S., et al. TWEAK induces liver progenitor cell proliferation. Journal of Clinical Investigation 115 (2005) 2330-2340
43. Jelnes P., Santoni-Rugiu E., Rasmussen M., Friis S.L., Nielsen J.H., Tygstrup N., et al. Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology 45 (2007) 1462-1470
44. Kakumu S., Okumura A., Ishikawa T., Yano M., Enomoto A., Nishimura H., et al. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clinical and Experimental Immunology 109 (1997) 458-463
45. Kamiya A., Kinoshita T., Ito Y., Matsui T., Morikawa Y., Senba E., et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO Journal 18 (1999) 2127-2136
46. Keating R., Yue W., Rutigliano J.A., So J., Olivas E., Thomas P.G., et al. Virus-specific CD8+ T cells in the liver: Armed and ready to kill. Journal of Immunology 178 (2007) 2737-2745
47. Kinoshita T., Sekiguchi T., Xu M.J., Ito Y., Kamiya A., Tsuji K., et al. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 96 (1999) 7265-7270
48. Kinosita R. Studies on the cancerogenic chemical substances. Transactions of the Society of Pathology Japan 27 (1937) 665-727
49. Kirman I., Vainer B., and Nielsen O.H. Interleukin-15 and its role in chronic inflammatory diseases. Inflammation Research 47 (1998) 285-289
50. Knight B., Akhurst B., Matthews V.B., Ruddell R.G., Ramm G.A., Abraham L.J., et al. Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice. Journal of Hepatology 46 (2006) 134-141
51. Knight B., Matthews V.B., Akhurst B., Croager E.J., Klinken E., Abraham L.J., et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunology and Cell Biology 83 (2005) 364-374
52. Knight B., and Yeoh G.C. TNF/LTalpha double knockout mice display abnormal inflammatory and regenerative responses to acute and chronic liver injury. Cell and Tissue Research 319 (2005) 61-70
53. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L.J., Yu C., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. Journal of Experimental Medicine 192 (2000) 1809-1818
54. Knolle P.A., and Gerken G. Local control of the immune response in the liver. Immunological Reviews 174 (2000) 21-34
55. Knolle P.A., Germann T., Treichel U., Uhrig A., Schmitt E., Hegenbarth S., et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. Journal of Immunology 162 (1999) 1401-1407
56. Knolle P.A., and Limmer A. Control of immune responses by savenger liver endothelial cells. Swiss Medical Weekly 133 (2003) 501-506
57. Kofman A.V., Morgan G., Kirschenbaum A., Osbeck J., Hussain M., Swenson S., et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 41 (2005) 1252-1261
58. Koniaris L.G., Zimmers-Koniaris T., Hsiao E.C., Chavin K., Sitzmann J.V., and Farber J.M. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. Journal of Immunology 167 (2001) 399-406
59. Laurence A., and O'Shea J.J. T(H)-17 differentiation: Of mice and men. Nature Immunology 8 (2007) 903-905
60. Lee J., Wu C.C., Lee K.J., Chuang T.H., Katakura K., Liu Y.T., et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proceedings of the National Academy of Sciences of the United States of America, 103 (2006) 1828-1833
61. Lesurtel M., Graf R., Aleil B., Walther D.J., Tian Y., Jochum W., et al. Platelet-derived serotonin mediates liver regeneration. Science 312 (2006) 104-107
62. Libbrecht L., Desmet V., Van Damme B., and Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: Can 'progenitor cells' migrate?. Journal of Pathology 192 (2000) 373-378
63. Libbrecht L., Desmet V., Van Damme B., and Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: Correlation with putative progenitor cells. Journal of Hepatology 33 (2000) 76-84
64. Lim R., Knight B., Patel K., McHutchison J.G., Yeoh G.C., and Olynyk J.K. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology 43 (2006) 1074-1083
65. Limmer A., and Knolle P.A. Liver sinusoidal endothelial cells: A new type of organ-resident antigen-presenting cell. Archivum Immunologiae et Therapiae Experimentalis 49 Suppl. 1 (2001) S7-S11
66. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nature Medicine 6 (2000) 1348-1354
67. Lowes K.N., Brennan B.A., Yeoh G.C., and Olynyk J.K. Oval cell numbers in human chronic liver diseases are directly related to disease severity. American Journal of Pathology 154 (1999) 537-541
68. Lowes K.N., Croager E.J., Abraham L.J., Olynyk J.K., and Yeoh G.C. Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut 52 (2003) 1327-1332
69. Malik R., Selden C., and Hodgson H. The role of non-parenchymal cells in liver growth. Seminars in Cell and Developmental Biology 13 (2002) 425-431
70. Matthews V.B., Klinken E., and Yeoh G.C. Direct effects of interleukin-6 on liver progenitor oval cells in culture. Wound Repair and Regeneration 12 (2004) 650-656
71. Matthews V.B., Knight B., Tirnitz-Parker J.E., Boon J., Olynyk J.K., and Yeoh G.C. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture. Experimental Cell Research 306 (2005) 252-263
72. Mavier P., Martin N., Couchie D., Preaux A.M., Laperche Y., and Zafrani E.S. Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. American Journal of Pathology 165 (2004) 1969-1977
73. Mead J.E., and Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proceedings of the National Academy of Sciences of the United States of America, 86 (1989) 1558-1562
74. Michalopoulos G.K., Barua L., and Bowen W.C. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 41 (2005) 535-544
75. Mitaka T., Sattler C.A., Sattler G.L., Sargent L.M., and Pitot H.C. Multiple cell cycles occur in rat hepatocytes cultured in the presence of nicotinamide and epidermal growth factor. Hepatology 13 (1991) 21-30
76. Mitchell C., Nivison M., Jackson L.F., Fox R., Lee D.C., Campbell J.S., et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. Journal of Biological Chemistry 280 (2005) 2562-2568
77. Nagy P., Kiss A., Schnur J., and Thorgeirsson S.S. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. Hepatology 28 (1998) 423-429
78. Nakamura K., Nonaka H., Saito H., Tanaka M., and Miyajima A. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39 (2004) 635-644
79. Nelsen C.J., Rickheim D.G., Tucker M.M., Hansen L.K., and Albrecht J.H. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. Journal of Biological Chemistry 278 (2003) 3656-3663
80. Nguyen L.N., Furuya M.H., Wolfraim L.A., Nguyen A.P., Holdren M.S., Campbell J.S., et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 45 (2007) 31-41
81. Oe S., Lemmer E.R., Conner E.A., Factor V.M., Leveen P., Larsson J., et al. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 40 (2004) 1098-1105
82. Olynyk J.K., Yeoh G.C., Ramm G.A., Clarke S.L., Hall P.M., Britton R.S., et al. Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. American Journal of Pathology 152 (1998) 347-352
83. Paku S., Schnur J., Nagy P., and Thorgeirsson S.S. Origin and structural evolution of the early proliferating oval cells in rat liver. American Journal of Pathology 158 (2001) 1313-1323
84. Petersen B.E. Hepatic "stem" cells: Coming full circle. Blood Cells, Molecules, and Diseases 27 (2001) 590-600
85. Petersen B.E., Goff J.P., Greenberger J.S., and Michalopoulos G.K. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 27 (1998) 433-445
86. Petersen B.E., Grossbard B., Hatch H., Pi L., Deng J., and Scott E.W. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 37 (2003) 632-640
87. Prezzi C., Casciaro M.A., Francavilla V., Schiaffella E., Finocchi L., Chircu L.V., et al. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. European Journal of Immunology 31 (2001) 894-906
88. Racanelli V., and Rehermann B. The liver as an immunological organ. Hepatology 43 (2006) S54-S62
89. Rosenberg D., Ilic Z., Yin L., and Sell S. Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury. Hepatology 31 (2000) 948-955
90. Roskams T., De Vos R., Van Eyken P., Myazaki H., Van Damme B., and Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: Evidence for hepatic progenitor cells in man. Journal of Hepatology 29 (1998) 455-463
91. Roskams T.A., Libbrecht L., and Desmet V.J. Progenitor cells in diseased human liver. Seminars in Liver Disease 23 (2003) 385-396
92. Roskams T.A., Theise N.D., Balabaud C., Bhagat G., Bhathal P.S., Bioulac-Sage P., et al. Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers. Hepatology 39 (2004) 1739-1745
93. Roskams T., Yang S.Q., Koteish A., Durnez A., DeVos R., Huang X., et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. American Journal of Pathology 163 (2003) 1301-1311
94. Sakamoto T., Ezure T., Lunz J., Murase N., Tsuji H., Fung J.J., et al. Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. Hepatology 32 (2000) 256-267
95. Sakamoto T., Liu Z., Murase N., Ezure T., Yokomuro S., Poli V., et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29 (1999) 403-411
96. Sanchez A., Factor V.M., Espinoza L.A., Schroeder I.S., and Thorgeirsson S.S. In vitro differentiation of rat liver derived stem cells results in sensitization to TNFalpha-mediated apoptosis. Hepatology 40 (2004) 590-599
97. Santoni-Rugiu E., Jelnes P., Thorgeirsson S.S., and Bisgaard H.C. Progenitor cells in liver regeneration: Molecular responses controlling their activation and expansion. Acta Pathologica, Microbiologica et Immunologica 113 (2005) 876-902
98. Selzner N., Selzner M., Odermatt B., Tian Y., Van Rooijen N., and Clavien P.A. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 124 (2003) 692-700
99. Shelly L.L., Tynan W., Schmid W., Schutz G., and Yeoh G.C. Hepatocyte differentiation in vitro: Initiation of tyrosine aminotransferase expression in cultured fetal rat hepatocytes. Journal of Cell Biology 109 (1989) 3403-3410
100. Snykers S., De Kock J., Vanhaecke T., and Rogiers V. Differentiation of neonatal rat epithelial cells from biliary origin into immature hepatic cells by sequential exposure to hepatogenic cytokines and growth factors reflecting liver development. Toxicology In Vitro 21 (2007) 1325-1331
101. Steffan A.M., Gendrault J.L., McCuskey R.S., McCuskey P.A., and Kirn A. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 6 (1986) 830-836
102. Stoop J.N., Woltman A.M., Biesta P.J., Kusters J.G., Kuipers E.J., Janssen H.L., et al. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response. Hepatology 46 (2007) 699-705
103. Strick-Marchand H., Morosan S., Charneau P., Kremsdorf D., and Weiss M.C. Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proceedings of the National Academy of Sciences of the United States of America, 101 (2004) 8360-8365
104. Subrata L.S., Lowes K.N., Olynyk J.K., Yeoh G.C., Quail E.A., and Abraham L.J. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: Transcriptional control mechanisms in oval cells and hepatoma cell lines. Liver International 25 (2005) 633-646
105. Suzuki A., McCall S., Choi S.S., Sicklick J.K., Huang J., Qi Y., et al. Interleukin-15 increases hepatic regenerative activity. Journal of Hepatology 45 (2006) 410-418
106. Taub R. Liver regeneration: From myth to mechanism. Nature Reviews Molecular Cell Biology 5 (2004) 836-847
107. Tirnitz-Parker J.E., Tonkin J.N., Knight B., Olynyk J.K., and Yeoh G.C. Isolation, culture and immortalisation of hepatic oval cells from adult mice fed a choline-deficient, ethionine-supplemented diet. International Journal of Biochemistry and Cell Biology 39 (2007) 2226-2239
108. Viebahn C.S., Tirnitz-Parker J.E., Olynyk J.K., and Yeoh G.C. Evaluation of the "Cellscreen" system for proliferation studies on liver progenitor cells. European Journal of Cell Biology 85 (2006) 1265-1274
109. Webber E.M., Godowski P.J., and Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 19 (1994) 489-497
110. Yeoh G.C., Ernst M., Rose-John S., Akhurst B., Payne C., Long S., et al. Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation. Hepatology 45 (2007) 486-494
111. Zheng D., Oh S.H., Jung Y., and Petersen B.E. Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1. American Journal of Pathology 169 (2006) 2066-2074